Longitudinal Endpoint Assessment of Disease Burden in HD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Longitudinal Endpoint Assessment of Disease Burden in HD — Stella

Home/Huntington Disease/

View on ClinicalTrials.gov

Recruiting

Back to Huntington Disease trials

Trial locations(1 site)

United States

Huntington Study Group, Rochester, New York

Key details

Sponsor

Huntington Study Group

Collaborators

University of Rochester Center for Health + Technology, Modality.AI, Inc

Enrollment target

~600 participants

Started

June 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.